What Influences Patient Outcome in Obstructive Airway Disease?

This study has been completed.
Information provided by:
University of Dundee
ClinicalTrials.gov Identifier:
First received: October 14, 2010
Last updated: October 19, 2010
Last verified: October 2010

The aim of this observational study is to utilise the established record linkage data available in Tayside to investigate hospital admissions, exacerbations and mortality in COPD.


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Beta-Blockers Reduce Mortality and Exacerbations When Added to Stepwise Inhaled Therapy for COPD Without Adverse Effects on Lung Function.

Further study details as provided by University of Dundee:

Primary Outcome Measures:
  • All-cause Mortality

Secondary Outcome Measures:
  • Hospital Admissions
  • COPD exacerbations

Enrollment: 5977
Study Start Date: August 2010
Estimated Study Completion Date: October 2010
Beta Blocker Use
No beta blocker use


Ages Eligible for Study:   50 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

COPD patients within NHS Tayside, UK


Inclusion Criteria:

  • Data collected through TARDIS database

Exclusion Criteria:

  • History of asthma or malignancy. Less than 50 years of age
  Contacts and Locations
No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Dr Philip M Short, University of Dundee
ClinicalTrials.gov Identifier: NCT01221480     History of Changes
Other Study ID Numbers: SHO002
Study First Received: October 14, 2010
Last Updated: October 19, 2010
Health Authority: United Kingdom: Tayside Medical Research Ethics Committee

Additional relevant MeSH terms:
Pulmonary Disease, Chronic Obstructive
Lung Diseases, Obstructive
Lung Diseases
Respiratory Tract Diseases
Adrenergic beta-Antagonists
Adrenergic Antagonists
Adrenergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on April 14, 2014